Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of tradi (Q46560454)
Jump to navigation
Jump to search
scientific article published on 20 June 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of tradi |
scientific article published on 20 June 2005 |
Statements
1 reference
Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of tradi (English)
1 reference
1 reference
Y Agid
1 reference
K Eggert
1 reference
H Widner
1 reference
K Ostergaard
1 reference
A Holopainen
1 reference
TC-INIT Study Group
1 reference
20 June 2005
1 reference
1 reference
53
1 reference
4
1 reference
197-202
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference